Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfram Brugger

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disordersKatja C Weisel, Wolfram Brugger, Stefan M Kröber, et al.
Haematologica|May 12, 2004
Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapyStefan Scheding, Markus Bergmannn, Gisa Rathke, et al.
Haematologica|October 14, 2003
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cellsVolker L Reichardt, Caterina Milazzo, Wolfram Brugger, et al.
Experimental Hematology|September 13, 2002
Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuliAlessio Nencioni, Kirsten Lauber, Frank Grünebach, et al.
Haematologica|February 27, 2003
Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cellsWichard Vogel, Frank Grünebach, Conrad A Messam, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2019
Phase I study of orally administered <sup>14</sup>Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignanciesAlexander MacDonald, Graeme Scarfe, Dominic Magirr, et al.
Annals of Hematology|December 30, 2014
Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2)Martin Henkes, Jürgen Finke, Klaus Warnatz, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN studyJulien Mazières, Wolfram Brugger, Federico Cappuzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approachesMartin R Müller, Frank Grünebach, Katrin Kayser, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2010
Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donorsHans-Georg Kopp, Stefan Wirths, Christoph Faul, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disordersKatja C Weisel, Wolfram Brugger, Stefan M Kröber, et al.
Haematologica|May 12, 2004
Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapyStefan Scheding, Markus Bergmannn, Gisa Rathke, et al.
Haematologica|October 14, 2003
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cellsVolker L Reichardt, Caterina Milazzo, Wolfram Brugger, et al.
Experimental Hematology|September 13, 2002
Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuliAlessio Nencioni, Kirsten Lauber, Frank Grünebach, et al.
Haematologica|February 27, 2003
Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cellsWichard Vogel, Frank Grünebach, Conrad A Messam, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2019
Phase I study of orally administered <sup>14</sup>Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignanciesAlexander MacDonald, Graeme Scarfe, Dominic Magirr, et al.
Annals of Hematology|December 30, 2014
Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2)Martin Henkes, Jürgen Finke, Klaus Warnatz, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN studyJulien Mazières, Wolfram Brugger, Federico Cappuzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approachesMartin R Müller, Frank Grünebach, Katrin Kayser, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2010
Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donorsHans-Georg Kopp, Stefan Wirths, Christoph Faul, et al.
Pageof 6